Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Gynecology
»
Breast Diseases
13. June 2026
Search
medline.ch
Breast Diseases
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Reproduction
Genital Diseases female
Infertility
Breast Diseases
Menopause
Pregnancy
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 10938
Articles 1 - 20 / 218750
Social Avoidance Trajectories, Core Characteristics and Maintenance Factors in Postoperative Breast Cancer Patients: A Longitudinal Mixed-Methods Study.
J Adv Nurs
Chunyan H, Xiaoping D, Xiao P, Chao W, Baohua C.
PMID: 42286942 [PubMed - as supplied by publisher]
Preclinical evaluation of a fluorinated bifendate derivative in triple-negative breast cancer: integrated in vitro and in vivo evidence of antitumor activity.
BMC Cancer
Lin LZ, Huang HY, Peng Y, Lin GQ, Hu J, Jiang Y.
PMID: 42286551 [PubMed - as supplied by publisher]
Letter to the Editor: Breast Implants or Lipofilling in Augmentation Mammoplasty? A Randomized, Open-Label, Controlled Trial.
Aesthetic Plast Surg
Dadhwal US.
PMID: 42286331 [PubMed - as supplied by publisher]
Adjuvant radiotherapy and skin cancer risk in breast cancer survivors: a nationwide cohort study in Korea.
Br J Cancer
Chin JH, Kim D, Lee HS, Jeon S, Lee JA, Lee YJ, Bae SY, Park WC, Song JH, Yoon CI.
PMID: 42286233 [PubMed - as supplied by publisher]
RE: Electroacupuncture improves cognitive function and neuropsychiatric symptoms in breast cancer survivors: a pilot randomized controlled trial.
J Natl Cancer Inst
Wang X, Xu X, Li Y.
PMID: 42286225 [PubMed - as supplied by publisher]
Anlotinib combined with neoadjuvant chemotherapy for HR+/HER2- breast cancer (ACNTBC): a prospective, single-arm, single-center phase II clinical study with real-world validation.
Signal Transduct Target Ther
Ding J, Meng H, Wang Y, Zi H, Li M, Chen H, Fan C, Wang S, Zhang L, Shang L, Kong J, Fan J, Wang T.
PMID: 42285923 [PubMed - in process]
Enhancing screening, early diagnosis and treatment initiation of oral, breast and cervical cancer in selected districts of India: an implementation research protocol.
BMJ Open
Kankaria A, Shukla P, Vijayakumar M, Sachdeva A, Subramanian MJ, Borah PK, Sahoo SS, Nirgude A, Prusty RK, T S S, Asuri K, Verma P, Sharma J, Dhaliwal RS, Begum S, Kaur T, ICMR-NHRP Cancer Screening Group.
PMID: 42285578 [PubMed - indexed for MEDLINE]
FSCL-BC: Federated supervised contrastive learning for breast cancer diagnosis with high sensitivity.
Comput Methods Programs Biomed
Ahmed F, Sánchez D, Haddi Z, Domingo-Ferrer J.
PMID: 42285014 [PubMed - as supplied by publisher]
Strengths and pitfalls of NNT and NNH in early breast cancer escalation trials.
Breast
Buonaiuto R, Mangiacotti FP, Giudici F, Tafuro M, Scarfetta R, Longobardi A, Pagliuca M, Caltavituro A, Arecco L, de Azambuja E, Giuliano M, Arpino G, Del Mastro L, De Angelis C, De Laurentiis M, Puglisi F.
PMID: 42285001 [PubMed - as supplied by publisher]
Machine learning defines a histone deacetylase-associated transcriptional prognostic signature with single-cell resolution in breast cancer.
Biochem Biophys Res Commun
Wang Y, Wang Y, Li Y, Xu Y, Kong L, Liu L, He L, Dai J.
PMID: 42284987 [PubMed - as supplied by publisher]
Breast cancer risk-reducing medications - featuring the new kid, "baby tam".
Maturitas
Klassen CL, Fraker J, Khatri L, Pruthi S.
PMID: 42284820 [PubMed - as supplied by publisher]
A retrospective and comparative study of 173 canine mammary papillae.
J Comp Pathol
Cassali GD, Souza FR, Dos Reys MP, Werner J, Nakagaki KYR.
PMID: 42284816 [PubMed - as supplied by publisher]
Cost-effectiveness analysis of mammography screening for early detection of breast cancer in Nigeria.
PLoS One
Nduka IJ, Okafor CE, Ekwunife OI.
PMID: 42284308 [PubMed - indexed for MEDLINE]
Multi-modal deep temporal adversarial network based on multi-head self-attention for breast cancer survival prediction.
Comput Methods Biomech Biomed Engin
Xu H, Xue H, Yuan H, Huang Z.
PMID: 42284062 [PubMed - as supplied by publisher]
Clinical characteristics of medication-related osteonecrosis of the jaw in breast cancer patients receiving zoledronic acid versus denosumab: a retrospective cohort study.
Maxillofac Plast Reconstr Surg
Kim JS, Hwang Y, Baek S, Ahn KM.
PMID: 42283988 [PubMed - as supplied by publisher]
Adenoid cystic carcinoma of the breast: a case series of 26 patients.
Breast Cancer Res Treat
Taleb I, Witmeyer S, Huck C, Fournier M, Auriol S, Debled M, Petit A, de la Rochefordiere A, Grogan GM, Tredan O, Bouleftour W, Méry B, Magné N.
PMID: 42283891 [PubMed - indexed for MEDLINE]
Correction: The impact of cardiovascular risk factors on cancer progression: a prospective study in female breast cancer survivors.
Breast Cancer Res Treat
Feng X, Deng Z, McCullough MS, May BJ, Selznick E, Sheng JY, Connor AE, Armstrong DK, Visvanathan K.
PMID: 42283870 [PubMed - in process]
Three-monthly gonadotropin-releasing hormone agonist for ovarian function suppression in premenopausal breast cancer: a systematic review and meta-analysis.
Breast Cancer Res Treat
de Liz CD, Reis PCA, Blanchard-Cavagis ER, Diniz IC, Brito HC, Visani FLV.
PMID: 42283761 [PubMed - in process]
Retraction Note: Commentary on: "A Long-Term Single-Center Study: Motivations and Strategies in Implant Management for Breast Augmentation Revision Surgery".
Aesthetic Plast Surg
Aphale P, Dokania S, Shekhar H.
PMID: 42283745 [PubMed - as supplied by publisher]
Clinical applications of PARP inhibitors in breast, ovarian, and prostate cancer: current insights and future directions.
Clin Adv Hematol Oncol
Linville LM, Canzoniero JV, Marshall CH, Armstrong DK, Markowski MC, Carducci MA.
PMID: 42283711 [PubMed - indexed for MEDLINE]
Articles 1 - 20 / 218750
Page 1 of 10938
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy